curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Breast Cancer; Prostate Cancer; Colorectal Cancer; Thyroid Cancer; Breast Cancer Stage III; Breast Cancer Stage IV; Prostate Cancer Stage III; Prostate Cancer Stage IV; Colorectal Cancer Stage III; Colorectal Cancer Stage IV; Thyroid Cancer Stage III;...

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Hidradenitis Suppurativa Interventions: Drug: SAR445399; Drug: Placebo Sponsors: Sanofi Not yet recruiting Conditions: Hidradenitis Suppurativa Interventions: Drug: SAR445399; Drug: Placebo Sponsors: Sanofi Not yet...

mHealth for Early Psychosis Caregivers in Statewide Program Outreach

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Caregiver; Caregiver Distress; Caregiver to a Young Adult With Early Psychosis; Family Caregivers Interventions: Behavioral: Bolster Sponsors: University of North Carolina, Chapel Hill; North Carolina Department of Health and Human Services Not yet...

A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Acute Pain Interventions: Drug: Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion) Sponsors: AFT Pharmaceuticals, Ltd. Not yet recruiting Conditions: Acute Pain Interventions:...

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) – Relapsing-remitting Interventions: Drug: Ublituximab Sponsors: Northwestern University; TG Therapeutics, Inc. Not yet recruiting Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) –...

Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Spinal Cord Injury Cervical; Spinal Cord Injuries (Complete and Incomplete) Interventions: Device: Brain Computer Interface (BCI) – Functional Electrical Stimulation (FES) system Sponsors: Case Western Reserve University; University Hospitals...
« Older Entries
Next Entries »

Recent Posts

  • A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease
  • Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVT
  • 4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis
  • The Effect of Body Percussion Training on Neuromotor Performance, Attention, and Functionality in Adolescents With Mild Intellectual Disability
  • Novel Labels to Improve Public Understanding of the Nicotine in Electronic Nicotine Delivery Systems: A Survey of Nicotine Concentration and Nicotine Flux

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®